GLP-1 medications can cause various side effects, with the most common being gastrointestinal (GI) ones, including nausea, vomiting, diarrhea, and constipation
Most patients report no issues during or after the infusion
By reducing NNMT catalytic activity, the compound allows researchers to evaluate how limiting nicotinamide methylation influences: In vitro and in vivo experimental models (non-clinical, non-human) have demonstrated that NNMT suppression leads to measurable changes in cellular energy markers and adipocyte behavior
The post says compounded formulations get shorter, more conservative expiration windows because they lack the comprehensive long-term stability data that industrial manufacturing and accelerated testing generate
Hence, understanding and implementing both is crucial for drug development
Additionally, if you experience dizziness, avoid driving or operating machinery until it subsides